Search research articles
Contact Us
Filters
Showing results (1-10 of 94) with videos related to
Page
of 10
Sort By:
Current Molecular Pharmacology
|
October 21, 2010
HIF-1 as a target for cancer chemotherapy, chemosensitization and chemoprevention
Elena Monti, Marzia B Gariboldi
The Journal of Physiology
|
October 6, 2022
Motor unit alterations with muscle disuse: what's new?
Fabio Sarto, Giacomo Valli, Elena Monti
Clinical Dysmorphology
|
November 27, 2009
Prenatal and postnatal growth retardation, depressed nasal tip, oligodactyly, and mental retardation
Elena Monti, Raoul C M Hennekam
Current Opinion in Drug Discovery & Development
|
April 1, 2009
Novel approaches on epigenetics
Roberto Papait, Elena Monti, Ian M Bonapace
Biochemical Pharmacology
|
May 22, 2010
The IGFR1 inhibitor NVP-AEW541 disrupts a pro-survival and pro-angiogenic IGF-STAT3-HIF1 pathway in human glioblastoma cells
Marzia B Gariboldi, Raffaella Ravizza, Elena Monti
European Journal of Pharmacology
|
June 12, 2020
Luteolin impairs hypoxia adaptation and progression in human breast and colon cancer cells
Elena Monti, Emanuela Marras, Pamela Prini, et al.
International Journal of Oncology
|
November 18, 2004
The piperidine nitroxide Tempol potentiates the cytotoxic effects of temozolomide in human glioblastoma cells
Raffaella Ravizza, Elena Cereda, Elena Monti, et al.
Oncology Reports
|
August 13, 2008
Linalool, a plant-derived monoterpene alcohol, reverses doxorubicin resistance in human breast adenocarcinoma cells
Raffaella Ravizza, Marzia B Gariboldi, Roberta Molteni, et al.
BMC Cancer
|
December 17, 2004
Role of the p53/p21 system in the response of human colon carcinoma cells to Doxorubicin
Raffaella Ravizza, Marzia B Gariboldi, Laura Passarelli, et al.
Pediatric Endocrinology Reviews : PER
|
July 18, 2013
Osteogenesis imperfecta
Mouna Ben Amor, Frank Rauch, Elena Monti, et al.
Page
of 10
Search research articles
Search
Showing results (1-10 of 94) with videos related to
Sort By:
Page
of 10
Current Molecular Pharmacology
|
October 21, 2010
HIF-1 as a target for cancer chemotherapy, chemosensitization and chemoprevention
Elena Monti, Marzia B Gariboldi
The Journal of Physiology
|
October 6, 2022
Motor unit alterations with muscle disuse: what's new?
Fabio Sarto, Giacomo Valli, Elena Monti
Clinical Dysmorphology
|
November 27, 2009
Prenatal and postnatal growth retardation, depressed nasal tip, oligodactyly, and mental retardation
Elena Monti, Raoul C M Hennekam
Current Opinion in Drug Discovery & Development
|
April 1, 2009
Novel approaches on epigenetics
Roberto Papait, Elena Monti, Ian M Bonapace
Biochemical Pharmacology
|
May 22, 2010
The IGFR1 inhibitor NVP-AEW541 disrupts a pro-survival and pro-angiogenic IGF-STAT3-HIF1 pathway in human glioblastoma cells
Marzia B Gariboldi, Raffaella Ravizza, Elena Monti
European Journal of Pharmacology
|
June 12, 2020
Luteolin impairs hypoxia adaptation and progression in human breast and colon cancer cells
Elena Monti, Emanuela Marras, Pamela Prini, et al.
International Journal of Oncology
|
November 18, 2004
The piperidine nitroxide Tempol potentiates the cytotoxic effects of temozolomide in human glioblastoma cells
Raffaella Ravizza, Elena Cereda, Elena Monti, et al.
Oncology Reports
|
August 13, 2008
Linalool, a plant-derived monoterpene alcohol, reverses doxorubicin resistance in human breast adenocarcinoma cells
Raffaella Ravizza, Marzia B Gariboldi, Roberta Molteni, et al.
BMC Cancer
|
December 17, 2004
Role of the p53/p21 system in the response of human colon carcinoma cells to Doxorubicin
Raffaella Ravizza, Marzia B Gariboldi, Laura Passarelli, et al.
Pediatric Endocrinology Reviews : PER
|
July 18, 2013
Osteogenesis imperfecta
Mouna Ben Amor, Frank Rauch, Elena Monti, et al.
Page
of 10